tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Wittes, 99 are a BUY (86.09%), 16 are a HOLD (13.91%).
Analyst Jason Wittes, carries an average stock price target met ratio of 58.48% that have a potential upside of 44.27% achieved within 281 days. Previously, Jason Wittes worked at ROTH MKM, AEGIS, LOOP CAPITAL, NORTHLAND CAPITAL MARKETS, BREAN.
Jason Wittes’s has documented 221 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on IRMD, Iradimed Co at 10-Feb-2026.
Analyst best performing recommendations are on PGNX (PROGENICS PHARMACEUTICALS).
The best stock recommendation documented was for NUVA (NUVASIVE) at 6/7/2016. The price target of $60 was fulfilled within 2 days with a profit of $2.11 (3.64%) receiving and performance score of 18.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4
$2.92 (270.37%)
$7
11 months 20 days ago
(06-Nov-2025)
0/3 (0%)
$2.78 (227.87%)
Buy
$9
$7.92 (733.33%)
2 years 8 months 13 days ago
(13-Feb-2024)
0/3 (0%)
$6.25 (227.27%)
Buy
$10
$8.92 (825.93%)
$10
5 years ago
(26-Oct-2021)
0/5 (0%)
$5.7 (132.56%)
Hold
$4.25
$3.17 (293.52%)
$4
7 years 3 months 16 days ago
(10-Jul-2019)
3/3 (100%)
$0.59 (16.12%)
99
